1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-(diethylamino)but-2-en-1-one

ID: ALA4636996

PubChem CID: 78322916

Max Phase: Preclinical

Molecular Formula: C32H33ClFN5O3

Molecular Weight: 590.10

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN(CC)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21

Standard InChI:  InChI=1S/C32H33ClFN5O3/c1-3-38(4-2)13-6-10-31(40)39-14-7-15-41-30-19-27-25(18-28(30)39)32(36-21-35-27)37-24-11-12-29(26(33)17-24)42-20-22-8-5-9-23(34)16-22/h5-6,8-12,16-19,21H,3-4,7,13-15,20H2,1-2H3,(H,35,36,37)/b10-6+

Standard InChI Key:  LRVQUKBVPJMLPP-UXBLZVDNSA-N

Molfile:  

 
     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
   23.8430   -7.0544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8422   -5.4171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5511   -5.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5503   -6.6471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2615   -7.0551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9739   -6.6461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9707   -5.8207    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2590   -5.4123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2562   -4.5909    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.9666   -4.1799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6791   -4.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3891   -4.1811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3867   -3.3589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6685   -2.9488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9615   -3.3656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1021   -4.5876    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.0966   -2.9428    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.8104   -3.3522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5161   -2.9361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2269   -3.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9363   -2.9342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9329   -2.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2141   -1.7069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5076   -2.1206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6499   -3.3439    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.1421   -5.8277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1388   -6.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4934   -7.1613    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.4977   -5.3122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.6914   -6.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6937   -5.4953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3377   -6.2387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4934   -4.4946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1989   -4.0822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.7835   -4.0897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0780   -4.5021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3681   -4.0973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6626   -4.5096    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9527   -4.1048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2472   -4.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6670   -5.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9614   -5.7392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 27  1  1  0
  1  4  2  0
  3  2  2  0
  2 26  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 26 27  2  0
 27 28  1  0
 26 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 31 32  1  0
 29 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 38 41  1  0
 41 42  1  0
M  END

Associated Targets(Human)

NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 590.10Molecular Weight (Monoisotopic): 589.2256AlogP: 6.76#Rotatable Bonds: 10
Polar Surface Area: 79.82Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.33CX LogP: 5.89CX LogD: 3.97
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.20Np Likeness Score: -1.44

References

1. Sun M, Jia J, Sun H, Wang F..  (2020)  Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold.,  30  (9): [PMID:32139324] [10.1016/j.bmcl.2020.127045]

Source